Professional Experience
Lawrence S. Perry has extensive experience practicing before the U.S. Patent and Trademark Office, including appeals, interferences, reexaminations, reissues and all phases of patent prosecution in biotechnical, chemical, pharmaceutical, plant genetics, magneto-optical, metallurgical and mechanical technologies. Mr. Perry has extensive opinion work concerning noninfringement, invalidity and freedom to practice in these and other fields.
Some of the Interferences Mr. Perry has worked on include:
Interference No. 102,090 involving circuit for driving multi element display devices.
Interference No. 102,091 involving method of maintaining display state in liquid crystal devices.
Interference No. 102,092 involving ferroelectric liquid crystal optical displays.
Interference No. 102,323 involving method of addressing liquid crystal displays.
Interference No. 102,393 involving DNA encoding GM-CSF.
Interference No. 103,046 involving method of producing misoprostol.
Interference No. 103,424 involving bone morphogenic proteins.
Interference No. 104,539 regarding photocurable cyanoacrylate compositions.
Some of the Appeals Mr. Perry has worked on include:
US Application No. 08/579,731 regarding optically active 2R, 4S benzothiepin isomer.
US Application No. 07/846,776 regarding cyclic nucleotide phosphodiesterase inhibitors.
US Application No. 07/474,648 regarding methods for producing L-threonine and L-glutamic acid using Corynebacterium or Brevibacterium containing E. coli threonine operon or phosphoenolpyruvic acid decarboxylase genes.
US Application No. 10/940,026 regarding methods of producing complex carbohydrate using Corynebacterium culture and nucleotide triphosphate
Mr. Perry has also lectured at various professional law associations:
· Lecturer, Schendel v. Curtis, New York Intellectual Property Law Association, Joint Patent Seminar, May 30, 1997
· Lecturer, Utility Requirements in Biotechnology Patent Applications, Philadelphia Intellectual Property Law Association, Joint Patent Seminar, April 12, 1995
· Lecturer, Patenting and Licensing of Human Monoclonal Antibodies, International Business Communications Annual Conference, February 7, 1994
· Lecturer, Understanding Monoclonal Antibodies, Hybridomas and Other Exotic Technologies, AIPLA Mid-Winter Conference, January 25, 1994
· Lecturer, Organizing Your Appeal Brief, Symposium on Practice Before the U.S.P.T.O. Board of Patent Appeals and Interferences, June 10, 1991
· Lecturer, Patenting in the Biological Arts, Joint Japanese Symposium, October 7, 2009
· Lecturer, Advanced Patent Prosecution, Practicing Law Institute, July 26-27, 2010
Awards and Recognition
Mr. Perry is listed in Legal 500 2008 for patent re-examination. He was also recognized in the 2011 edition of Who's Who of Patent Lawyers.
For information on the selection process, see:
Legal 500
Who's Who Legal
Professional Activities
American and New York Bar Associations (ABA IPL Committee and Patent, Trademark and Copyright Section Committee on Reexamination); American and New York Intellectual Property Lawyers Associations (AIPLA Biotechnology and Interference Committees); Intellectual Property Owners Association (IPO Patent Law Committee); Biotechnology Industry Organization; New York Biotechnology Association
Additional Publications
"Untangling the Nanothreads Between the Enablement and Written Description Requirements," Nanotechnology Law & Business, March 2007.
"Property Rights in Living Matter: Is New Law Required?," 68 Den.U.L.Rev.2.
Publications
IP Monetisation Due Diligence: The Duration of Exclusivity II
Financier Worldwide
October 2011
Untangling the Nanothreads Between the Enablement and Written Description Requirements
Nanotechnology Law & Business
March 2007